چھاتی کا کینسر
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
کہاں جانا ہے
1 ہسپتال انڈیا میں اس ٹرائل کے لیے مریض لے رہا ہے۔
رجسٹری کی سمری (ٹیکنیکل)
The Nanosomal Docetaxel Lipid Suspension (NDLS) consists of uniformly sized micro particles of docetaxel suspended in a lipid based formulation. The advantage of such a Lipid Based formulation of Docetaxel is an improvement of the safety profile by eliminating excipients, polysorbate 80 and ethanol which are present in conventional Docetaxel formulations (Taxotere®). This randomized, open-label study is designed to assess the efficacy and safety of Nanosomal Docetaxel Lipid Suspension at the dose of 75 mg/m2 and at the dose of 100 mg/m2 compared to Taxotere® at the dose of 100 mg/m2 in triple-…
سپانسر: جینا فارماسیوٹیکلز انک.
NCT03671044 on ClinicalTrials.gov
رجسٹری میں آخری اپ ڈیٹ 21 مارچ 2025 · ہم نے پڑھا 20 اکتوبر 2026